FDA Inspection 1336054 — LEASEIR TECHNOLOGIES SLU

LEASEIR TECHNOLOGIES SLU — FEI 3023344928

The FDA completed an inspection of LEASEIR TECHNOLOGIES SLU on Sep 2, 2026 in Gijon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 8 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Sep 2, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Gijon (Spain)

Citations

IDCFRDescription
23024ISO 13485:2016 Clause 4.1.5Inadequate monitoring and control over outsourced processes
23127ISO 13485:2016 Clause 7.3.8Design and development transfer procedures not documented
23145ISO 13485:2016 Clause 7.4.1Records of supplier (re)evaluation, selection, and monitoring not maintained
23164ISO 13485:2016 Clause 7.5.4Records of servicing activities not maintained
23215ISO 13485:2016 Clause 8.2.2Complaint handling procedures lack required elements
23251ISO 13485:2016 Clause 8.4Data analysis did not include data from monitoring, measurement, other sources
23258ISO 13485:2016 Clause 8.5.2Corrective action procedures not documented
23260ISO 13485:2016 Clause 8.5.3Preventive action not determined

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.